Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Operating Income
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
B
|
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
Operating Income
¥1.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income?
Operating Income
1.4B
CNY
Based on the financial report for Dec 31, 2023, Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income amounts to 1.4B CNY.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
55%
Over the last year, the Operating Income growth was -74%. The average annual Operating Income growth rates for Beijing Wantai Biological Pharmacy Enterprise Co Ltd have been 22% over the past three years , 55% over the past five years .